Kimberly-Clark Corporation
KMB · Nasdaq
- $98.15
- $32.96B
- Open
- —
- —
- $98.98 - $100.92
- $92.42 - $129.87
- —
- —
- 6.38M
About Kimberly-Clark Corporation
Kimberly-Clark sells branded consumer and professional products, including personal-care, tissue, family-care and hygiene products. Its customers include households buying through retail and e-commerce channels, as well as healthcare, commercial and institutional users. The company makes money primarily from product sales, with pricing, volume, mix, productivity and input costs driving profitability. The supplied evidence does not provide a current segment revenue split or each segment’s contribution. Kimberly-Clark generated $16.4 billion of revenue and $2.0 billion of net income in FY2025, compared with $16.8 billion and $2.5 billion, respectively, in FY2024.
Notable Price Movement
- Aug 3-7$109.680.34%
Kimberly-Clark fell $1.52, or 1.34%, from $113.09 to $111.57 over the supplied week. The stock first weakened sharply, dropping to $110.19 on July 30, $109.31 on July 31 and $107.56 on August 3, before rebounding to $111.57 on August 4. The evidence does not identify company-specific news behind the initial decline or provide broader market context. The reversal coincided with second-quarter results and the earnings call: adjusted earnings rose 10.4% and gross margin expanded, but sales missed estimates, China pressured organic growth, and management lowered its outlook amid one-time disruptions and a softer consumer backdrop. The rebound therefore recovered much of the pre-results decline but did not erase the weekly loss.
